CME GROUP INC. — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that CME GROUP INC. filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.52B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $6.13B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $5.58B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $5.02B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $4.69B | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $1.10B | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $1.08B | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $1.18B | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $1.52B | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $1.14B | Feb 26, 2021 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.07B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.53B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $3.23B | Feb 26, 2026 |
| FY2025 | Dec 31, 2022 | $2.69B | Feb 26, 2026 |
| FY2025 | Dec 31, 2021 | $2.64B | Feb 26, 2026 |
| FY2020 | Dec 31, 2020 | $424.00M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $411.70M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $503.30M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $766.20M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $469.50M | Feb 26, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.23B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.93B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $3.44B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $3.02B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.65B | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | $515.00M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $525.00M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $637.50M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $959.90M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $573.00M | Feb 26, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.28B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $3.69B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $3.45B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $3.06B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.40B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $2.72B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $2.67B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $2.44B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $1.75B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.73B | Feb 28, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $83.50M | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $94.00M | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $76.40M | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $89.70M | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $127.20M | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $197.50M | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $245.60M | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $116.70M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $81.90M | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $91.80M | Feb 28, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $198.42B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $137.45B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $129.71B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $174.18B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $196.78B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $124.66B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $75.22B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $77.48B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $75.79B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $69.37B | Mar 1, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $169.70B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $110.96B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $102.97B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $147.30B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $169.38B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $98.31B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $49.06B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $51.51B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $53.38B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $49.03B | Mar 1, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $28.73B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $26.49B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $26.74B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $26.88B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $27.40B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $26.32B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $26.13B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $25.92B | Feb 28, 2020 |
| FY2019 | Dec 31, 2017 | $22.41B | Feb 28, 2020 |
| FY2019 | Dec 31, 2016 | $20.34B | Feb 28, 2020 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $10.51B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $10.49B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $10.50B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $10.48B | Feb 27, 2025 |
| FY2022 | Dec 31, 2021 | $10.53B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $10.80B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $10.74B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $10.81B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $7.57B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $7.57B | Mar 1, 2018 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.43B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $4.19B | Feb 26, 2026 |
| FY2024 | Dec 31, 2023 | $4.46B | Feb 27, 2025 |
| FY2023 | Dec 31, 2022 | $4.75B | Feb 28, 2024 |
| FY2022 | Dec 31, 2021 | $5.15B | Feb 27, 2023 |
| FY2021 | Dec 31, 2020 | $5.00B | Feb 25, 2022 |
| FY2020 | Dec 31, 2019 | $5.01B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $4.86B | Feb 28, 2020 |
| FY2018 | Dec 31, 2017 | $4.50B | Feb 28, 2019 |
| FY2017 | Dec 31, 2016 | $2.52B | Mar 1, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $4.42B | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | $2.89B | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | $2.91B | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | $2.72B | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | $2.83B | Feb 28, 2024 |
| FY2022 | Dec 31, 2020 | $1.63B | Feb 27, 2023 |
| FY2021 | Dec 31, 2019 | $1.55B | Feb 25, 2022 |
| FY2020 | Dec 31, 2018 | $1.37B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $1.90B | Feb 28, 2020 |
| FY2018 | Dec 31, 2016 | $1.87B | Feb 28, 2019 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 9 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 7 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 2 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 26, 2021 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 11 | Feb 26, 2026 |
| FY2025 | Dec 31, 2024 | 9 | Feb 26, 2026 |
| FY2025 | Dec 31, 2023 | 8 | Feb 26, 2026 |
| FY2024 | Dec 31, 2022 | 7 | Feb 27, 2025 |
| FY2023 | Dec 31, 2021 | 7 | Feb 28, 2024 |
| FY2020 | Dec 31, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | 1 | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | 2 | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | 1 | Feb 26, 2021 |